Age-related Macular Degeneration (AMD) is responsible for the majority of registered blindness in the elderly. Laser photocoagulation can be offered as a treatment of proven value to only a proportion of patients with neovascular AMD.
number of ageing eyes for which there is no place for laser. In addition to improve ments in education, referral habits and the application of laser therapy which may have an impact upon visual loss due to AMD, there are promising directions to be explored in alternative modes of treatment and prevention.
It is well recognised that the leading cause of 
